Page 63 - EJMO-9-2
P. 63

Eurasian Journal of
            Medicine and Oncology                                    TCM regulates gut microbiota in pediatric MP pneumonia



            while Enterobacteriaceae decreased following intervention   regulate the immune system, reduce adverse reactions, and
            with Ginseng Ling Baijusan, which mitigated antibiotic-  provide anti-inflammatory and antiviral effects through a
            associated adverse reactions.                      multi-target and multi-component mechanism of action,
                                                               considering the child as a whole. In conclusion, the
              Pneumolysin, one of the major virulence factors
            of  Streptococcus  pneumoniae,  enhances bacterial   combined treatment of MPP in children using TCM and
                                      71
                                                               Western medicines is both effective and safe, warranting
            colonization and drug resistance, helping S. pneumoniae   extensive attention and in-depth research in both academic
            evade immune clearance by suppressing the host immune   and clinical settings.
                                      73
                   72
            response.  Studies have shown  that pneumolysin can
            activate inflammatory signaling pathways in intestinal   During our review, we identified RCTs of TCM based
            epithelial cells (e.g., NOD-like receptor family pyrin   on intestinal microbiota modulation for the treatment
            domain containing 3 [NLRP3]) inflammasome, leading   of children with MPP, starting with changes in intestinal
            to the release of pro-inflammatory factors (e.g., IL-1β, and   microbiota modulation by TCM. We conducted a meta-
            IL-18) and triggering intestinal inflammation. Moreover,   analysis of the 11 included studies using Stata 12.0 software.
            pneumolysin can increase intestinal permeability and   The results revealed that the overall clinical effectiveness
            disrupt barrier function by disrupting tight junction   rate of combining Western medicine and TCM for
            proteins (e.g., zona occluden-1 and occludin) in intestinal   treating MPP in children was higher compared to Western
            epithelial cells, thereby promoting the infection and spread   medicine alone. The analysis indicated that the treatment
            of pneumonia. In contrast, a study by Guo et al.  found   with TCM increased the number of probiotics, such as
                                                    74
            that Ma Xing Shi Gan Tang not only affects the oligomeric   Bifidobacteria and  Lactobacilli, and reduced the count
            state of pneumolysin, reducing its activity and protecting   of pathogenic bacteria like  Enterobacteriaceae, thereby
            the intestinal barrier but also promotes the production of   improving the inflammatory response. Concurrently,
            beneficial intestinal bacteria and SCFAs, thereby alleviating   immune function showed improvements, with increased
            pneumonia exacerbated by immune dysregulation. 75,76   levels of cluster of differentiation (CD)4⁺ and the CD4⁺/
            Experimental results showed that Ma Xing Shi Gan Tang   CD8⁺  ratio  in  children,  as  well  as  increased  levels  of
            significantly attenuated lung pathological damage and   secretory immunoglobulin A in saliva and feces. In terms of
            reduced mortality in mice infected with  S. pneumoniae.   inflammation, the level of TNF-α significantly decreased.
            Rhodopsin  inhibits the  NLRP3 inflammasome-mediated   The study’s results demonstrated that TCM treatment for
            neutrophil  recruitment  and  lysis  signaling  pathways,   MPP offers significant advantages in enhancing clinical
            thereby ameliorating lipopolysaccharide-induced lung   effectiveness and modulating the systemic immune
            injury.  Thus, herbal interventions can treat pulmonary   response by regulating intestinal microbiota and restoring
                 77
            systemic diseases by modulating relevant inflammatory   homeostasis in children. In the authors’ view, TCM can
            factors, mucosal immunity, protein expression, and   mitigate the inflammatory response in children, ameliorate
            maintaining the homeostatic balance of the pulmonary   immune imbalances, enhance immune capabilities, and
            and intestinal microbiota.                         repair lung and intestinal mucosal barrier damage by
                                                               modulating the intestinal microbiota, thereby achieving
              In exploring effective treatment options for MPP in   the goal of treating MPP.
            children, the combination of TCM and Western medicine
            therapies has demonstrated unique advantages. Clinical   4.3. Limitations and shortcomings
            practice has shown that  the use of pediatric elimination   This study has several limitations: (i) some of the included
                               78
            of accumulation and relieving cough oral solution,   studies had small sample sizes, and specific blinding
            combined with doxycycline, can significantly shorten   implementation  protocols  were  not  reported,  potentially
            the duration of symptoms such as fever, cough, and lung   affecting  the  stability  and  authenticity  of  the  results;
            rales, while effectively reducing levels of inflammatory   (ii) several studies did not mention adverse reactions or
            markers such as TNF-α and C-reactive protein, compared   safety evaluations, which limits the completeness and
            to the doxycycline-only treatment group. Furthermore, the   comprehensiveness  of  this  study;  (iii)  the  trial  group
            combination of Xuanbai Chengqi Tang and azithromycin   involved Chinese medicine therapy, and due to the limited
            effectively regulates immune imbalances in children with   coverage of such studies in foreign journals, the included
            MPP  and  alleviates  acute-phase  symptoms.   In  clinical   literature was all in Chinese, with China as the primary
                                                79
            settings, antibiotics directly inhibit or kill M. pneumoniae,   study area, which may introduce potential bias; (iv) most
            demonstrating rapid onset of action and significant   of the literature did not address the children’s follow-up
            pathogen inhibition and anti-inflammatory effects.   status, and the absence of long-term follow-up data makes
            The combined use of TCM and Western medicines can   the trial’s long-term effectiveness unclear, rendering


            Volume 9 Issue 2 (2025)                         55                              doi: 10.36922/ejmo.8602
   58   59   60   61   62   63   64   65   66   67   68